Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/05/1997 | EP0804597A1 Activation of t-cells by modified, antigenic immunoglobulins |
11/05/1997 | EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
11/05/1997 | EP0804595A1 Synthetic proteins as implantables |
11/05/1997 | EP0804594A1 Plant genes affecting gibberellic acid biosynthesis |
11/05/1997 | EP0804593A1 Recombinant hk2 polypeptide |
11/05/1997 | EP0804592A1 Calcium free subtilisin mutants |
11/05/1997 | EP0804591A1 Serum paraoxonase |
11/05/1997 | EP0804590A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
11/05/1997 | EP0804589A1 Neural receptor tyrosine kinase |
11/05/1997 | EP0804587A1 Mutant luciferases |
11/05/1997 | EP0804586A2 $g(b)-KETOACYL ACP REDUCTASE GENES FROM BRASSICA NAPUS |
11/05/1997 | EP0804585A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer |
11/05/1997 | EP0804584A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
11/05/1997 | EP0804583A2 Lettuce infectious yellows virus genes |
11/05/1997 | EP0804582A1 $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS |
11/05/1997 | EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
11/05/1997 | EP0804580A1 Calcium binding recombinant antibody against protein c |
11/05/1997 | EP0804579A1 Antibodies which bind to insect gut proteins and their use |
11/05/1997 | EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor |
11/05/1997 | EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR |
11/05/1997 | EP0804576A1 A novel haemopoietin receptor |
11/05/1997 | EP0804575A1 G protein coupled receptor protein, production, and use thereof |
11/05/1997 | EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof |
11/05/1997 | EP0804573A1 Methods and compositions for modulating morphogenic protein expression |
11/05/1997 | EP0804572A1 Protein tyrosine kinase agonist antibodies |
11/05/1997 | EP0804571A1 Spider neurotoxins and method of producing the same |
11/05/1997 | EP0804570A1 Vaccines against helminthic parasites |
11/05/1997 | EP0804569A2 Expression of human d 4? dopamine receptors in stable cell lines |
11/05/1997 | EP0804568A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
11/05/1997 | EP0804567A1 Method for the ex vivo treatment of tumour cells from patients with cml |
11/05/1997 | EP0804566A1 Blue light photoreceptors and methods of using the same |
11/05/1997 | EP0804565A1 Tetracycline-regulated transcriptional modulators |
11/05/1997 | EP0804564A1 Neural axon outgrowth modulators |
11/05/1997 | EP0804563A1 Antisense oligonucleotide generators |
11/05/1997 | EP0804562A1 Connective tissue growth factor-2 |
11/05/1997 | EP0804561A1 Regulated transcription of targeted genes and other biological events |
11/05/1997 | EP0804560A1 Plant xylose isomerase |
11/05/1997 | EP0804559A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
11/05/1997 | EP0804558A2 Tripeptidyl aminopeptidase |
11/05/1997 | EP0804557A1 Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
11/05/1997 | EP0804556A1 Protein modifying enzyme |
11/05/1997 | EP0804555A1 A monoclonal antibody to human ventricular myosin light chains |
11/05/1997 | EP0804554A1 Preparation of immortalized cells |
11/05/1997 | EP0804552A1 Redirection of cellular immunity by receptor chimeras |
11/05/1997 | EP0804548A1 Patched genes and their use |
11/05/1997 | EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
11/05/1997 | EP0804546A1 Human prostatic specific reductase |
11/05/1997 | EP0804486A2 Granulocyte chemotactic protein |
11/05/1997 | EP0804485A1 Trypsin inhibitor protein from pentaclethra macroloba having insecticidal properties |
11/05/1997 | EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
11/05/1997 | EP0804482A1 Cytokines that bind the cell surface receptor hek |
11/05/1997 | EP0804480A1 Purified thrombopoietin and method of making it |
11/05/1997 | EP0804479A1 Method of treating diabetes mellitus using kgf |
11/05/1997 | EP0804472A1 Mosaic polypeptide and methods for detecting the hepatitis e virus |
11/05/1997 | EP0804467A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
11/05/1997 | EP0804458A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
11/05/1997 | EP0804457A1 Modified green fluorescenct proteins |
11/05/1997 | EP0804455A1 Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal rna precursors |
11/05/1997 | EP0804453A1 Method for detection and treatment of breast cancer |
11/05/1997 | EP0804452A1 Recombinant c140 receptor and its agonists and antagonists |
11/05/1997 | EP0804451A1 Lung cancer marker |
11/05/1997 | EP0804448A1 Method for the purification of short nucleic acids |
11/05/1997 | EP0804446A1 Method and composition for stabilization of labelled nucleoside triphosphates |
11/05/1997 | EP0804414A1 Complementary dna and toxins |
11/05/1997 | EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
11/05/1997 | EP0804232A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
11/05/1997 | EP0804230A1 Vaccine against mycobacterial infections |
11/05/1997 | EP0804226A1 Human choline acetyltransferase |
11/05/1997 | EP0804222A1 Accessory factor function for interferon gamma and its receptor |
11/05/1997 | EP0804219A1 Inhibin compositions and methods of use thereof |
11/05/1997 | EP0804218A1 Product and process for regulating signal transduction pathways |
11/05/1997 | EP0804214A1 Growth differentiation factor-6 |
11/05/1997 | EP0804210A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells |
11/05/1997 | EP0804087A1 Stable compositions comprising transgenic plant material |
11/05/1997 | EP0804076A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
11/05/1997 | EP0804070A1 Isolation of components of interest from milk |
11/05/1997 | EP0804066A1 Transgenic plants with altered senescence characteristics |
11/05/1997 | EP0804065A1 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
11/05/1997 | EP0738272B1 Method and separation substrate for analysing mononucleotides and oligonucleotides |
11/05/1997 | EP0703989B1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
11/05/1997 | EP0650528B1 Process for categorising nucleotide sequence populations |
11/05/1997 | EP0635068B1 Amplification of human mdm2 gene in human tumors |
11/05/1997 | EP0487718B1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety |
11/05/1997 | CN1164260A Reduction of nonspecific hybridization by using novel base-pairing schemes |
11/05/1997 | CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens |
11/05/1997 | CN1164236A Method of identifying compounds useful for treating autoimmune diseases |
11/05/1997 | CN1164194A Remedy for diseases caused by IL-6 production |
11/05/1997 | CN1164193A Human chemokine polypeptides |
11/05/1997 | CN1163937A Method of amplifying gene using artificial transposon |
11/05/1997 | CN1163936A Recombination eukaryotic vector containing sensitinogen gene and application thereof |
11/05/1997 | CN1163935A Five urokinase variant gene and its expression in colibacillus |
11/05/1997 | CN1163934A Protein with thrombocytopoietic factor active |
11/05/1997 | CN1163933A Protein with thrombocytopoietic factor active |
11/05/1997 | CN1163896A Transfection competent molecules |
11/04/1997 | US5684242 Cytoplasmic male sterility |
11/04/1997 | US5684241 Genetic engineering |
11/04/1997 | US5684239 Monocot having dicot wound-inducible promoter |
11/04/1997 | US5684238 Biosynthesis of zeaxanthin and glycosylated zeaxanthin in genetically engineered hosts |
11/04/1997 | US5684222 Mutant mouse having a disrupted TNFRp55 |
11/04/1997 | US5684221 Mammalian model of a malignant disorder |